glp-1 news september 2025 obesity drug today The GLP-1 trend: What the real-world data reveals GLP-1 - 9/4/2025

Allergy Asthma Clin Immunol 19(1):2

Trials excluded patients with prediabetes, and the abovementioned observational studies included patients with higher HbA1c levels at baseline, affecting the comparability

Then clinical practice

If you or a loved one developed gastroparesis requiring medical treatment after using Ozempic or other GLP-1 medications, you may be eligible to seek compensation

Cardiometabolic Benefits : Lower blood pressure and inflammation markers in certain contexts

Recent Highlights : Lilly began executing one of the largest pharmaceutical manufacturing expansions in its history, which included major new investments in North Carolina to support demand for injectable therapies